TG and fetal growth restriction: Clinical findings of reduced circulating thyroid hormone concentrations in severe IUGR fetuses prompted further investigations of the potential therapeutic role of peripartum thyroid hormone treatment; however, the reader is referred to the recent review of LaFranchi (2021) [59], which summarizes the mixed results of clinical trials and comments on unresolved questions and the main current areas of controversy surrounding this treatment.